Inventor
BHAT BALKRISHEN
US79 patents
⚠️ This page may combine multiple inventors who share the name “BHAT BALKRISHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
16 patentsUS9005906B2Apr 14, 2015
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC163 citations99
US8030467B2Oct 4, 2011
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC327 citations99
US7750131B2Jul 6, 2010
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC202 citations99
US7696345B2Apr 13, 2010
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ISIS PHARMACEUTICALS INC426 citations99
US7547684B2Jun 16, 2009
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC413 citations99
US7105499B2Sep 12, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC233 citations99
US6528631B1Mar 4, 2003
Oligonucleotide-folate conjugates
ISIS PHARMACEUTICALS INC461 citations99
US6335434B1Jan 1, 2002
Nucleosidic and non-nucleosidic folate conjugates
ISIS PHARMACEUTICALS INC558 citations99
US8796437B2Aug 5, 2014
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC85 citations98
US7939677B2May 10, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC152 citations98
US7875733B2Jan 25, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC159 citations98
US7569686B1Aug 4, 2009
Compounds and methods for synthesis of bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC501 citations98
US6861514B2Mar 1, 2005
Nucleosidic and non-nucleosidic folate conjugates
ISIS PHARMACEUTICALS INC122 citations98
US6420549B1Jul 16, 2002
Oligonucleotide analogs having modified dimers
ISIS PHARMACEUTICALS INC48 citations96
US7919612B2Apr 5, 2011
2′-substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC14 citations92
US7812149B2Oct 12, 2010
2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC12 citations84
REGULUS THERAPEUTICS INC
12 patentsUS9506030B2Nov 29, 2016
Compounds and methods for enhanced cellular uptake
REGULUS THERAPEUTICS INC18 citations93
US8912161B2Dec 16, 2014
MicroRNA compounds and methods for modulating miR-21 activity
REGULUS THERAPEUTICS INC15 citations93
US9359609B2Jun 7, 2016
Methods for treatment of alport syndrome
REGULUS THERAPEUTICS INC26 citations92
US9309513B2Apr 12, 2016
MicroRNA compounds and methods for modulating miR-122
REGULUS THERAPEUTICS INC13 citations92
US9012423B2Apr 21, 2015
Methods for treatment of alport syndrome
REGULUS THERAPEUTICS INC13 citations90
US9790496B2Oct 17, 2017
Microrna compounds and methods for modulating MIR-21 activity
REGULUS THERAPEUTICS INC4 citations84
US9574194B2Feb 21, 2017
MicroRNA compounds and methods for modulating miR-122
REGULUS THERAPEUTICS INC5 citations84
US9157083B2Oct 13, 2015
MicroRNA compounds and methods for modulating miR-122
REGULUS THERAPEUTICS INC9 citations84
US9139832B2Sep 22, 2015
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
REGULUS THERAPEUTICS INC4 citations84
US9688985B2Jun 27, 2017
MicroRNA compounds and methods for modulating miR-21 activity
REGULUS THERAPEUTICS INC6 citations83
US9267137B2Feb 23, 2016
MicroRNA compounds and methods for modulating miR-21 activity
REGULUS THERAPEUTICS INC8 citations83
US8969317B2Mar 3, 2015
MicroRNA compounds and methods for modulating miR-21 activity
REGULUS THERAPEUTICS INC9 citations83
ALLERSON CHARLES
5 patentsUS8124745B2Feb 28, 2012
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ALLERSON CHARLES203 citations98
US8604183B2Dec 10, 2013
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES20 citations92
US9150605B2Oct 6, 2015
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
US9150606B2Oct 6, 2015
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
ALLERSON CHARLES9 citations84
US8779118B2Jul 15, 2014
Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
ALLERSON CHARLES14 citations84
MERCK & CO INC
4 patentsUS7534767B2May 19, 2009
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC69 citations98
US7323449B2Jan 29, 2008
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC58 citations98
US7125855B2Oct 24, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC301 citations98
US6777395B2Aug 17, 2004
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus
MERCK & CO INC356 citations98
SWAYZE ERIC E
3 patentsLILLY CO ELI
2 patentsESAU CHRISTINE
2 patentsBHAT BALKRISHEN
2 patentsIONIS PHARMACEUTICALS INC
2 patentsSETH PUNIT P
1 patentMIGAWA MICHAEL T
1 patentShowing the top 50 of 79 patents by PatentIndex Score.